ANIK logo

ANIKAnika Therapeutics Inc.

$14.16
$0.25
(1.74%)
Pre-Market
Updated: 07:29 AM EDT·Prev Close $14.41
EarningsJul 29
Mkt Cap$191.73M
Vol413.00
44

Bearish Sentiment

How do you feel about ANIK?

News
all
press releases
Anika Therapeutics (NASDAQ:ANIK) Director John Henneman III Buys 5,000 Shares
Anika Therapeutics Inc. (NASDAQ:ANIK - Get Free Report) Director John Henneman III acquired 5,000 shares of the stock in a transaction on Friday, May 1st. The shares were acquired at an average price of $14.66 per share, with a total value of $73,300.00. Following the transaction, the director...
MarketBeat
News Placeholder
More News
News Placeholder
Anika Therapeutics (NASDAQ:ANIK) CEO Stephen Griffin Purchases 12,200 Shares
Anika Therapeutics Inc. (NASDAQ:ANIK - Get Free Report) CEO Stephen Griffin purchased 12,200 shares of the firm's stock in a transaction that occurred on Thursday, April 30th. The shares were bought...
MarketBeat
News Placeholder
Anika Therapeutics (NASDAQ:ANIK) CEO Purchases $149,938.00 in Stock
Anika Therapeutics Inc. (NASDAQ:ANIK - Get Free Report) CEO Stephen Griffin bought 12,200 shares of the firm's stock in a transaction on Thursday, April 30th. The stock was purchased at an average...
MarketBeat
News Placeholder
Anika Therapeutics (NASDAQ:ANIK) Releases Earnings Results, Misses Expectations By $0.17 EPS
Anika Therapeutics (NASDAQ:ANIK - Get Free Report) posted its quarterly earnings data on Wednesday. The biotechnology company reported ($0.24) EPS for the quarter, missing analysts' consensus...
MarketBeat
News Placeholder
Anika Therapeutics Q1 Earnings Call Highlights
Anika Therapeutics (NASDAQ:ANIK) reported first-quarter 2026 results highlighting continued momentum in its commercial channel, progress in its hyaluronic acid (HA)-based product pipeline, and early...
MarketBeat
News Placeholder
Anika Therapeutics (NASDAQ:ANIK) Share Price Crosses Above Two Hundred Day Moving Average - Time to Sell?
Anika Therapeutics (NASDAQ:ANIK) Stock Price Passes Above Two Hundred Day Moving Average - Time to Sell...
MarketBeat
News Placeholder
Anika Therapeutics (NASDAQ:ANIK) Stock Crosses Above 200 Day Moving Average - Should You Sell?
Anika Therapeutics (NASDAQ:ANIK) Stock Price Crosses Above Two Hundred Day Moving Average - Time to Sell...
MarketBeat
News Placeholder
Anika Therapeutics (NASDAQ:ANIK) Share Price Passes Above 200 Day Moving Average - What's Next?
Anika Therapeutics (NASDAQ:ANIK) Stock Passes Above 200 Day Moving Average - What's Next...
MarketBeat
News Placeholder
Anika Therapeutics (NASDAQ:ANIK) Share Price Crosses Above 200-Day Moving Average - Time to Sell?
Anika Therapeutics (NASDAQ:ANIK) Share Price Crosses Above 200-Day Moving Average - Here's Why...
MarketBeat
News Placeholder
Anika Therapeutics (NASDAQ:ANIK) Shares Pass Above 200-Day Moving Average - What's Next?
Anika Therapeutics (NASDAQ:ANIK) Share Price Passes Above 200-Day Moving Average - Here's What Happened...
MarketBeat
<
1
2
...
>